FR2666657A1 - Methode pour determiner le risque d'evolution d'une infection provoquee par hiv et sa mise en óoeuvre. - Google Patents

Methode pour determiner le risque d'evolution d'une infection provoquee par hiv et sa mise en óoeuvre. Download PDF

Info

Publication number
FR2666657A1
FR2666657A1 FR9111118A FR9111118A FR2666657A1 FR 2666657 A1 FR2666657 A1 FR 2666657A1 FR 9111118 A FR9111118 A FR 9111118A FR 9111118 A FR9111118 A FR 9111118A FR 2666657 A1 FR2666657 A1 FR 2666657A1
Authority
FR
France
Prior art keywords
dhea
amount
hiv
sample
risk
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR9111118A
Other languages
English (en)
French (fr)
Other versions
FR2666657B1 (ko
Inventor
Masterson Joseph Gerard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Perrigo Co PLC
Original Assignee
Elan Corp PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elan Corp PLC filed Critical Elan Corp PLC
Publication of FR2666657A1 publication Critical patent/FR2666657A1/fr
Application granted granted Critical
Publication of FR2666657B1 publication Critical patent/FR2666657B1/fr
Granted legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FR9111118A 1990-09-10 1991-09-09 Methode pour determiner le risque d'evolution d'une infection provoquee par hiv et sa mise en óoeuvre. Granted FR2666657A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IE326690A IE63418B1 (en) 1990-09-10 1990-09-10 Progression risk of HIV by assay of dehydroepiandrosterone in body fluid

Publications (2)

Publication Number Publication Date
FR2666657A1 true FR2666657A1 (fr) 1992-03-13
FR2666657B1 FR2666657B1 (ko) 1997-02-21

Family

ID=11038235

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9111118A Granted FR2666657A1 (fr) 1990-09-10 1991-09-09 Methode pour determiner le risque d'evolution d'une infection provoquee par hiv et sa mise en óoeuvre.

Country Status (6)

Country Link
JP (1) JPH04351964A (ko)
DE (1) DE4129932A1 (ko)
FR (1) FR2666657A1 (ko)
GB (1) GB2249833B (ko)
IE (1) IE63418B1 (ko)
IT (1) IT1255009B (ko)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4230684A (en) * 1978-03-16 1980-10-28 Cornell Research Foundation, Inc. Method for determining steroids in human body liquids
DE3812595A1 (de) * 1987-04-16 1988-10-27 Colthurst Ltd Arzneimittel zur prophylaxe und therapie von retrovirus-infektionen
WO1990008959A1 (en) * 1989-02-01 1990-08-09 E.I. Du Pont De Nemours And Company HIV p17 ASSAYS FOR MONITORING DEVELOPMENT OF AIDS
EP0383313A2 (en) * 1989-02-15 1990-08-22 Mochida Pharmaceutical Co., Ltd. Reagent for immunoassay, and kit containing the same

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4230684A (en) * 1978-03-16 1980-10-28 Cornell Research Foundation, Inc. Method for determining steroids in human body liquids
DE3812595A1 (de) * 1987-04-16 1988-10-27 Colthurst Ltd Arzneimittel zur prophylaxe und therapie von retrovirus-infektionen
WO1990008959A1 (en) * 1989-02-01 1990-08-09 E.I. Du Pont De Nemours And Company HIV p17 ASSAYS FOR MONITORING DEVELOPMENT OF AIDS
EP0383313A2 (en) * 1989-02-15 1990-08-22 Mochida Pharmaceutical Co., Ltd. Reagent for immunoassay, and kit containing the same

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
KALIMI ET AL. 'The biologic role of dehydroepiandrosterone (DHEA)' 1990 , DE GRUYTER , BERLIN Merril et al.: 'Reduced plasma dehydroepiandrosterone concentrations in HIV infection and Alzheimer's disease' *
LA PRESSE MéDICALE vol. 30, 10 Septembre 1988, PARIS page 1540 BRICAIRE ET AL. 'Taux des hormones sexuelles et du cortisol chez les malades .....' *
THE JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM vol. 70, no. 3, Mars 1990, PHILADELPHIA, PA pages 572 - 577 VILLETTE ET AL. 'Circadian variations in plasma levels of hypophyseal, adrenocortical ........' *
THE JOURNAL OF INFECTIOUS DISEASES vol. 164, no. 5, Novembre 1991, CHICAGO, ILL. pages 864 - 868 JACOBSON ET AL. 'Decreased serum dehydroepiandosterone is associated with an increased progression .......' *

Also Published As

Publication number Publication date
ITMI912378A0 (it) 1991-09-09
GB9119256D0 (en) 1991-10-23
GB2249833B (en) 1994-09-07
GB2249833A (en) 1992-05-20
IE63418B1 (en) 1995-04-19
IT1255009B (it) 1995-10-11
ITMI912378A1 (it) 1993-03-09
JPH04351964A (ja) 1992-12-07
DE4129932A1 (de) 1992-03-12
FR2666657B1 (ko) 1997-02-21

Similar Documents

Publication Publication Date Title
Smith et al. C4d fixing, luminex binding antibodies—a new tool for prediction of graft failure after heart transplantation
Jubault et al. Sequential occurrence of thyroid autoantibodies and Graves’ disease after immune restoration in severely immunocompromised human immunodeficiency virus-1-infected patients
Rao et al. An avidin-biotin microELISA for rapid measurement of total and allergen-specific human IgE
EP0399024A1 (fr) ANTICORPS MONOCLONAUX ANTI-INTERLEUKINES 1$g(a) ET 1$g(b), LEUR PROCEDE DE PRODUCTION ET APPLICATIONS DESDITS ANTICORPS A LA DETECTION DES INTERLEUKINES 1$g(a) et 1$g(b) ET EN THERAPEUTIQUE
Maddison et al. The relationship of race, sex, and age to concentrations of serum immunoglobulins expressed in international units in healthy adults in the USA
EP0311492B1 (fr) Trousse et méthode de dosage immunométrique applicables à des cellules entières
EP1336109B1 (fr) Trousse et procede de detection de la proteine esm-1
WO1993003381A1 (en) Assay for free secretory component and methods for monitoring organ rejection
Beutner et al. Sensitivity and specificity of IgA-class antiendomysial antibodies for dermatitis herpetiformis and findings relevant to their pathogenic significance
WO1992008983A1 (en) Hiv marker/aids vaccine
JPS63159762A (ja) 口内微生物の評価方法
CA2721049C (fr) Procede de diagnostic d'une hypertension arterielle pulmonaire
EP0676052B1 (fr) Detection de la mucoviscidose ou d'une mutation du gene cftr
DK173838B1 (da) Fremgangsmåde til påvisning af tilstedeværelsen af et blodpladecelleoverfladeantigen
FR2666657A1 (fr) Methode pour determiner le risque d'evolution d'une infection provoquee par hiv et sa mise en óoeuvre.
HUE030649T2 (en) Procedure for Anticipating the Progress of HIV Disease
CA2148268A1 (fr) Methode d'immunodosage specifique de la glutathion peroxydase plasmatique humaine
EP0801744B1 (fr) Reactif peptidique permettant de detecter une infection primaire a virus d'epstein-barr par recherche des anticorps correspondants, et procede d'utilisation de ce reactif
JPH11190734A (ja) クローン病の検査方法および検査用キット
JP3499875B2 (ja) 解離性大動脈瘤を検出するための抗体試薬及びその用途
EP0419367B1 (fr) Procédé de détection d'une substance biologique à l'aide de ligands
EP0920628B1 (fr) NOUVELLE METHODE D'ANALYSE DES RECEPTEURS PLAQUETTAIRES GPIIb/IIIa
Drouet et al. Quantification and molecular analysis of plasmatic HLA‐BCw molecules with a locus B and Cw HLA specific mAb (B1. 23.2 mAb)
FR2495326A1 (fr) Procede de dosage immunologique, du type a agglutination, pour deceler des anticorps de type immunoglobuline
JP2001508544A (ja) インフルエンザに対する血清α−Ｎ−アセチルガラクトサミニダーゼの診断用および予後判定用ＥＬＩＳＡアッセイ

Legal Events

Date Code Title Description
TP Transmission of property